VeriMomhydroxyresveratrol hamilelikte güvenli mi?
No regulatory prohibition or harmonised CLP CMR classification was found for hydroxyresveratrol/oxyresveratrol (CAS 29700-22-9), and no published reproductive/developmental toxicity or human teratogenicity data specific to oxyresveratrol were identified in searches of PubMed and regulatory sources. PubChem and supplier datasheets identify the substance (synonym oxyresveratrol) and physicochemical properties (logP ≈3.2) consistent with some potential for dermal absorption, so topical use could give low but measurable systemic exposure in adults. Sources: PubChem; supplier/product pages; PubMed searches for reproductive data (no oxyresveratrol-specific repro studies found).
Pregnancy-safe products containing hydroxyresveratrol
Related ingredients
Frequently asked questions
- hydroxyresveratrol hamilelikte güvenli mi?
- No regulatory prohibition or harmonised CLP CMR classification was found for hydroxyresveratrol/oxyresveratrol (CAS 29700-22-9), and no published reproductive/developmental toxicity or human teratogenicity data specific to oxyresveratrol were identified in searches of PubMed and regulatory sources. PubChem and supplier datasheets identify the substance (synonym oxyresveratrol) and physicochemical properties (logP ≈3.2) consistent with some potential for dermal absorption, so topical use could give low but measurable systemic exposure in adults. Sources: PubChem; supplier/product pages; PubMed searches for reproductive data (no oxyresveratrol-specific repro studies found).
- hydroxyresveratrol emzirirken güvenli mi?
- No evidence of harm to lactation or breastfeeding infants specific to oxyresveratrol was found. Because relevant human/animal lactation transfer data are lacking, and topical use can produce low systemic exposure, the conservative exposure score is low/measurable (e=1) but there is no mechanistic or reproductive evidence to raise hazard. Referenced supplier and chemical databases show identity and use in cosmetics; no CIR/SCCS/harmonised CLP classification was identified. (See sources.)
- hydroxyresveratrol bebek cildi için güvenli mi?
- No infant-specific safety or developmental skin studies were identified. Oxyresveratrol (INCI: hydroxyresveratrol) is used as a topical cosmetic active (skin-lightening/antioxidant). Given measurable dermal absorption in adults is plausible (logP ≈3.2) and immature infant skin increases per‑kg exposure, exposure for 0–3‑year skin is increased by one category vs adults (adult e=1 → baby e=2). There is no infant-specific hazard or mechanism data to increase h or m. Sources: supplier/COSmetic ingredient listings and PubChem. (No EU Annex II/III/banned/restricted listings found.)
- VeriMom hydroxyresveratrol nasıl puanlıyor?
- VeriMom hydroxyresveratrol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte hydroxyresveratrol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.